Skip to main content
Log in

Priming effect of recombinant vaccinia virus coding for the middle hepatitis B surface antigen

  • Brief Report
  • Published:
Archives of Virology Aims and scope Submit manuscript

Summary

Recombinant vaccinia virus expressing the middle hepatitis B virus surface antigen was incapable of inducing marked antibody response against the S and pre-S2 antigenic specifities in mice. However, mice immunized with this virus produced antibodies to both these antigens after the following administration of subtreshold doses of plasmatic hepatitis B surface antigen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Allen PM (1987) Antigen processing at the molecular level. Immunol Today 8: 270–273

    Google Scholar 

  2. Budkowska A, Riottot MM, Dubreuil P, Lazizi Y, Brechot C, Sobczak E, Petit MA, Pillot J (1986) Monoclonal antibody recognizing pre-S2 epitope and anti-pre-S(2) antibody. J Med Virol 20: 111–125

    Google Scholar 

  3. Cheng K-C, Moss B (1987) Selective synthesis and secretion of particles composed of the hepatitis B virus middle surface protein directed by a recombinant vaccinia virus: induction of antibodies to pre-S and S epitopes. J Virol 61: 1286–1290

    Google Scholar 

  4. Coursaget P, Adamowicz P, Bourdil C, Yvonnet B, Buisson Y, Barres J-L, Saliou P, Chiron J-P, Mar ID (1988) Anti-pre-S2 antibodies in natural hepatitis B virus infection and after immunization. Vaccine 6: 357–361

    Google Scholar 

  5. Joklik WK (1962) The purification of four strains of poxvirus. Virology 18: 9–18

    Google Scholar 

  6. Kutinová L, Němečková S, Hamšiková E, Press M, Závadová H, Hirsch I, Němeček V, Krchňák V, Smrt J, Slonim D, Vonka V (1990) A recombinant vaccinia virus expressing hepatitis B virus middle surface protein. Arch Virol 112: 181–193

    Google Scholar 

  7. Mackett M, Smith GL, Moss B (1984) General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J Virol 49: 857–864

    Google Scholar 

  8. Milich DR, Thornton GB, Neurath AR, Kent SD, Michel ML, Tiollais P, Chisari FV (1985) Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science 228: 1195–1199

    Google Scholar 

  9. Moss B, Smith GL, Gerin JL, Purcell RH (1984) Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature 311: 67–68

    Google Scholar 

  10. Pourcel C, Louise A, Gervais M, Chenciner N, Dubois MP, Tiollais P (1982) Transcription of the hepatitis B surface antigen in mouse cells transformed with cloned viral DNA. J Virol 42: 100–105

    Google Scholar 

  11. Slonim D, Hulenová M (1969) Study of plaque titration of vaccinia virus in chick embryo cell cultures. I. Assays under an agar overlay. Acta Virol 13: 209–215

    Google Scholar 

  12. Topp WC (1981) Normal rat cell lines deficient in nuclear thymidine kinase. Virology 113: 408–411

    Google Scholar 

  13. Townsend ARM (1987) Recognition of influenza virus proteins by cytotoxic T lymphocytes. Immunol Res 6: 80–100

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hamšíková, E., Závadová, H., Kutinová, L. et al. Priming effect of recombinant vaccinia virus coding for the middle hepatitis B surface antigen. Archives of Virology 113, 283–289 (1990). https://doi.org/10.1007/BF01316681

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01316681

Keywords

Navigation